PESCITELLI, LEONARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.195
EU - Europa 728
AS - Asia 180
OC - Oceania 3
AF - Africa 1
Totale 2.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.194
PL - Polonia 264
IE - Irlanda 148
IT - Italia 110
SE - Svezia 110
HK - Hong Kong 78
CN - Cina 33
SG - Singapore 33
RU - Federazione Russa 31
JO - Giordania 20
GB - Regno Unito 17
FI - Finlandia 16
DE - Germania 14
CH - Svizzera 6
UA - Ucraina 6
TR - Turchia 5
IR - Iran 4
VN - Vietnam 4
AU - Australia 3
ES - Italia 2
FR - Francia 2
IN - India 2
CA - Canada 1
KR - Corea 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
Totale 2.107
Salva come PNG Salva come JPEG
Città #
Warsaw 264
Chandler 203
Dublin 148
Fairfield 144
Woodbridge 81
Lawrence 75
Altamura 73
Seattle 60
Wilmington 53
Ashburn 52
Cambridge 52
Houston 49
Hong Kong 44
Princeton 41
Buffalo 40
Medford 40
Florence 20
Ann Arbor 19
Singapore 19
Shanghai 17
San Diego 16
Kent 15
Jacksonville 13
Norwalk 12
Boardman 11
Beijing 9
Boston 7
Bern 6
Izmir 5
Andover 4
Hillsboro 4
London 4
Los Angeles 4
Cagliari 3
El Paso 3
Falls Church 3
Saint Petersburg 3
Arezzo 2
Barcelona 2
Cento 2
Laurel 2
Moscow 2
Prescot 2
Redwood City 2
Reggio Emilia 2
Tappahannock 2
West Bloomfield 2
Acton 1
Arnsberg 1
Basking Ridge 1
Bremen 1
Chicago 1
Downers Grove 1
Gunzenhausen 1
Hanover 1
Islington 1
Ivanhoe 1
Monteriggioni 1
Munich 1
New Bedfont 1
Oslo 1
Phoenix 1
Rome 1
San Vito al Tagliamento 1
Seoul 1
Tehran 1
Toronto 1
Trumbull 1
Wuhan 1
Totale 1.658
Salva come PNG Salva come JPEG
Nome #
The involvement of Smac/DIABLO, p53, NF-kB and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: protective effects of curcumin and capsaicin 223
Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. 185
The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. 130
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. 118
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. 106
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 82
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 80
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 75
Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin. 71
Evidence for oxidative stress in the plasma of psoriatic patients: Source of ROS and results of treatments with biologics 66
Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment 61
NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by Psoriasis 47
Source of oxidative stress in fibroblasts from patients affected by psoriasis 41
Curcumin and capsaicin prevent mitochondrial damage and apoptosis in keratinocytes from perilesional vitiligo skin 40
Clinical experience with infliximab biosimilar in psoriasis 39
Clinical characteristics of psoriasis in inflammatory bowel disease patients 39
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?” 39
Cutaneous hyperpigmentation induced by apremilast 38
Vitiligo masks malignant acanthosis nigricans in a woman with ovarian cancer 37
Reduction in psoriasis related pruritus during biologic therapy* 36
Clinical experience with the etanercept biosimilar SB4 in psoriatic patients 36
Mitochondrial Damage and Apoptosis in Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin 35
Oxidative stress in the pathogenesis of vitiligo 34
Vitiligo: Ultrastructure, oxidative stress and apoptosis in perilesional skin 34
Ultrastructural mitochondrial alterations and oxidative damage in keratinocytes from perilesional vitiligo skin 34
Possible reconsideration of the Nail Psoriasis Severity Index (NAPSI) score 34
A pediatric case of sclerodermatous graft-versus-host disease responsive to ultraviolet A1 phototherapy 33
First case of secukinumab successful therapy in a very elderly psoriatic patient 33
Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis 33
Oxidative stress markers in psoriatic patients plasma and NADPH oxidase as a source of oxidative stress in fibroblasts 31
Erythrodermic psoriasis treated with ustekinumab: An Italian multicenter retrospective analysis 30
Hidradenitis suppurativa and associated diseases 30
Epidermal barrier reaction to an in vitro psoriatic microenvironment 29
Intellectual Disability and Hidradenitis Suppurativa 27
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 26
The role of Smac/DIABLO, p53, NF-kB, and MAPKs in Apoptosis of Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin. 24
Effect of a psoriatic microenvironment in a three-dimensional model of normal human skin 23
Novel therapeutic approaches and targets for the treatment of atopic dermatitis 22
Tuberculosis reactivation risk in dermatology 19
Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature 19
Totale 2.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020323 31 25 9 25 41 36 33 39 34 23 17 10
2020/2021186 19 17 13 17 7 20 5 22 17 24 12 13
2021/2022273 9 11 12 1 2 35 24 19 6 17 69 68
2022/2023778 64 188 42 54 62 141 75 40 75 2 19 16
2023/2024206 15 21 44 7 10 11 9 50 1 8 23 7
2024/202568 68 0 0 0 0 0 0 0 0 0 0 0
Totale 2.139